|
|
|||||||
ARTICLES |
,
,
* Walter Reed Army Institute of Research, Division
of Pathology, 503 Robert Grant Avenue, Silver Spring, MD 20910;
Emory University, 201 Dowman Road, Atlanta, GA
30322;
Cornell University, Department of
Biomolecular and Chemical Engineering, Ithaca, NY 14850
Submitted October 8, 2004; Revised February 7, 2005; Accepted March 30, 2005
| ABSTRACT |
|---|
|
|
|---|
Key Words: undergraduate secondary mouse tumor cells breast cancer personalized cancer management genomic profiling cellular drug resistance assay
| INTRODUCTION |
|---|
|
|
|---|
The breast cancer experiment was designed to be a concise, 5-d independent project. For most undergraduates, this study becomes their first experience with a multiday experiment and its attendant accountability. In our facility, mentors have used the breast cancer assay as a rapid assessment of the undergraduate's overall abilities. For the high school student, there is the excitement of discovery and working with actual cells. The undergraduates appreciate its summation of common cell biology techniques, and the younger teens enjoy generating their own data and solving the mystery.
The modified antiproliferative drug assay was selected as an experimental model because it is broadly applicable (Anonymous, 1999). In addition, it engages students with its robust response of dead or live cells. Student researchers use in vitro mouse mammary tumor (MMT) cultures and common chemotherapeutic drugs for the assay. Three common cancer regimensantioxidant, anti-inflammatory, and antimitoticare tested (Krzystyniak, 2002; Lou and Chen, 2003). Over-the-counter drugs such as aspirin are often included to demonstrate ineffectual therapies. Spectrophotometer readings provide students with an instrumental and mathematical measure of cell viability. This 5-d immersion in cell biology experimentation delivers the excitement of discovery in a cogent framework that integrates multiple technical skills. Furthermore, it requires students to synthesize content knowledge into a single effort.
| BACKGROUND FOR INSTRUCTOR |
|---|
|
|
|---|
Personalized cancer management merges standard chemotherapy and radiation treatments with genomic profiling and in vitro cell proliferation studies. Individualized genomic profiling allows the researcher to identify specific genes that contribute to unregulated cellular proliferation as well as those genes that inhibit the apoptotic mechanisms that normally control cellular growth (Evan and Vousden, 2001; Lou and Chen, 2003; Radice, 2002). By determining the molecular profile of a particular cancer, rational treatment regimens can be designed that focus on those gene products that are either hyperactive or inactive in a particular tumor. A patient's genome can also reveal susceptibility to certain toxic effects of chemotherapeutic agents (Strauss, 1999).
| MATERIALS AND METHODS |
|---|
|
|
|---|
Below are brief summaries of each day's expectations. Appendices A through C provide detailed instructions for instructors or advanced students. Student handouts for days 1 through 5 (Appendix D) consist of detailed protocols and questions that guide student activity and thinking. It is assumed that the instructor will maintain sufficient cultures and drug stocks and has introduced students to basic techniques and skills.
Day 1. Day 1 begins with a brief interactive discussion or review about the origin and evolution of cancer. As newly christened research assistants, the students then receive their daily outlines and are referred to the laboratory supplies table and handed a conical tube of MMT cell culture. The student/team then prepares two 96-well plates and incubates the cells overnight.
Day 2. Students confirm cell viability and confluence. All students complete a Drug Assay Worksheet (Appendix E) that is verified by the instructor. The student/team receives two samples of an unknown cancer treatment drug or combination of drugs. The completed Drug Assay Worksheet becomes the individualized protocol for that numbered drug(s). After preparing and diluting the original stock solution, students add the various concentrations of drugs to their plates. Cells are incubated with the drugs for 48 h.
Day 3. At the beginning of day 3, the class is given an aliquot of MMT cells. Referring to a worksheet that outlines the steps of using the hemocytometer, the student learns to do a cell count and dilution. Day 3 is also a day for further discussion and beginning the report.
Day 4. In preparation for data from the spectrophotometer, the students learn to analyze sample figures, create plots, and carry out simple statistical analyses on sample data using both Microsoft Excel software and the statistical analysis features of the TI-83 graphing calculator. Cells complete the second incubation day and are placed in a freezer overnight.
Day 5. Students treat each sample well with CyQUANT lysis buffer and the fluorescent dye. The plates are scanned with a Multifluor FX scanner, and students analyze the data by taking the average intensity for each concentration of the drug used in each treatment and comparing it with the control wells. After analyzing their data, students contribute their information for group discussion and their drugs are revealed.
Assessment. For undergraduates, a written laboratory report with a level-appropriate rubric is designed by the senior scientist. Precollege students are required to submit their final plots, which are then compared with standards. Many precollege students also complete a laboratory report and/or a poster. It should be noted that the two undergraduate authors on this report began their research while in high school. The essentials of how assessment is conducted within a military facility are detailed below.
Mouse Mammary Tumor Cell Culture and Maintenance
MMT 060562 cells and all cell culture media and reagents were purchased
from the American Type Culture Collection (ATCC; Manassas, VA). The MMT cells
were maintained according to the manufacturer's instructions in Eagle's
Minimal Essential medium that was modified by ATCC to contain 1.0 mM sodium
pyruvate, 0.1 mM nonessential amino acids, and 1.5 g/L sodium bicarbonate. The
medium was supplemented with 10% fetal bovine serum and 1% Pen-Strep (10,000
units/mL penicillin and 100 µg/mL streptomycin). Cell culture flasks were
maintained in a humidified 5% CO2 incubator at 37°C. Cell
viability was regularly checked with an inverted microscope. The cells were
subcultured at a 1:2 ratio as needed, and media were changed every other day
(Figure 1, Appendix A).
|
70% confluence after 24 h. The MMT cells were
then treated with varying concentrations of several therapeutic agents (or
combinations of agents): curcumin, nordihydroguaiaretic acid (NDGA),
tamoxifen, tamoxifen and curcumin, and tamoxifen and NDGA (Appendix C).
Control and treated cells were incubated for 48 h at 37°C and 5%
CO2. (Secondary students who ask to test an over-the-counter drug
or an herbal remedy can request an additional plate and develop their own
dilutions/concentrations. These results become a science fair project.)
Cellular Proliferation Assay
Following a 48-h incubation period, the 96-well plates containing the
drug-treated cancer cells were removed from the incubator. All media were
removed, and the plates were frozen for at least 30 min at 80°C or
overnight in a 20°C or 4°C freezer. Students prepared
reagents from the CyQUANT Cell Proliferation Assay Kit (Molecular Probes,
Eugene, OR) according to the manufacturer's instructions. The CyQUANT kit was
selected as a convenient and sensitive procedure for determining the density
of cells in culture. Cells were simply thawed and lysed by addition of a
buffer containing the CyQUANT GR dye to each well
(Anonymous, 1999). A green
fluorescent dye, CyQUANT GR exhibits stronger fluorescent characteristics upon
binding to cellular nucleic acids. The degree of fluorescence is then
determined by scanning the plates with BioRad's Multifluor FX scanner and
analyzing the images with QuantityOne software (BioRad, Hercules, CA).
During analysis, students convert pixel values corresponding to the scanned image of each sample well to numerical values that represent the adjusted volume (cells/mm2) of cells in each sample. Standard school calculators are used to give the student researchers an introduction to research mathematics beginning with basic algebra. The intern then learns/reviews how to use a spreadsheet to analyze data exported from the scanner and how to create plots of cell density versus various concentrations of their unknown drug or combination of drugs compared with untreated controls.
Antiproliferative Therapeutic Agents for Treatment of Breast Cancer
Tamoxifen is an antimitotic drug that has been used against advanced breast
cancer in postmenopausal, hormone-sensitive patients for over 20 yr
(Grandishar, 2004). For
hormone-sensitive neoplasms, the mix of estrogen receptor subtypes, or
isoforms, is slightly modified to allow maximal estrogen binding and thus
maximal stimulus for cellular proliferation. Although tamoxifen remains a
successful antiestrogen therapy, recent research has revealed some serious
shortcomings. First, it is now known that approximately 25% of breast cancers
are not estrogen stimulated, making tamoxifen inconsequential. Second, only
half of estrogen-sensitive cancers successfully respond to tamoxifen because
of induced tamoxifen resistance by the enzyme protein kinase A
(Chagpar, 2004). As a
phytoestrogen, a traditional drug with well-documented effects, and a
well-known hormonal antagonist, tamoxifen was selected as a test drug suitable
for students.
Curcumin, a yellow compound from the turmeric root, is found in various Asian and Middle Eastern herbal remedies and cuisines. Its inhibitory effect on growth has been shown to be time- and dose-dependent and is correlated with the inhibition of ornithine decarboxylase (ODC) activity (Mehta and Pantazis, 1997). Interestingly, the enzyme ODC is used to manufacture a class of proteins, polyamines, that cause cancer cells to grow more rapidly. Curcumin also exhibits a modest ability to arrest cancerous cells in the G2S phase of the cell cycle and suppress c-jun/AP-1 and NF-kappa B activation pathways, and it possesses limited anti-inflammatory activity. Patients often use curcumin as a nutritional adjuvant to standard chemotherapy (Wallace, 2002) because even limited suppression of inflammatory eicosanoids appears to decrease the growth of breast carcinomas (Krzystyniak, 2002; Teh and Hill, 2004).
NDGA, commonly found in chaparral tea, is a constituent of the creosote bush Larrea divaricata. Historically, it has been used in Native American remedies for cramping, joint pain, allergies, parasites, and cancer (McGuffin and Hobbs, 1997). As a powerful antioxidant, NDGA was investigated as a possible cancer treatment. In vitro research has shown that NDGA acts as a selective inhibitor of lipoxygenases (LOX), platelet-derived growth factor receptors, and protein kinase C intracellular signaling compounds. Each of these protein families plays an important role in the proliferation and survival of cancer. Current research has focused on finding more potent analogs of NDGA to ameliorate the high concentrations of the compound that are required for therapeutic efficacy (McDonald and Bunjobpon, 2001; Sheikh and Philen, 1997; Tong and Ding, 2002).
The activity of the antiestrogen agent, tamoxifen, was tested both individually and in combination with curcumin and NDGA. Because both curcumin and NDGA target disparate classes of proteins, it was hoped that the activity of tamoxifen would be augmented by the use of these supplementary agents. Curcumin and NDGA have historically been used as unconventional, alternative treatments for breast cancer.
| RESULTS |
|---|
|
|
|---|
Of the three, tamoxifen appeared to be the most potent treatment. Figure 2 shows the culture plate for MMT cells treated with tamoxifen at increasing concentrations from left to right. Tamoxifen induced a significant inhibition in cell growth of more than 85% compared with the untreated cells (Figure 3A). These high reductions in cell proliferation show no indication of tamoxifen resistance, as would be expected in a short, 2-d incubation. In vitro conditions cannot accurately simulate in vivo estrogen availability or physiological response to prolonged tamoxifen therapy. Longer incubation periods under in vivo estrogen levels might allow time for the cells to develop the compensatory mutations and alterations in the estrogen receptor composition and pathways.
|
|
NDGA treatment resulted in the least dramatic reduction, with proliferation relative to the control populations decreased by 20% (Figure 3B). The students considered two sources of error. The students considered 1) testing more concentrated doses of NDGA or 2) increasing the length of time the cells were exposed to the less concentrated doses. The NDGA results are consistent with the mixed endorsement of the plant derivative as a dependable supplement to current breast cancer treatments. Oncologists remain hesitant to recommend the high doses of NDGA that would be needed to obtain the results of alternative treatments because of its hepatotoxic effects (Lambert and Zhao, 2002).
Curcumin-treated MMT samples exhibited concentration-dependent inhibition of unregulated cellular growth. The drug's antiproliferative ability caused a significant inhibition of cell growth of more than 80% in the treated samples compared with the untreated control (Figure 3C).
The combination of tamoxifen and curcumin proved to be less effective than the use of tamoxifen or curcumin individually. The extent of inhibition of cell proliferation by the combination of tamoxifen and curcumin was less than the inhibition observed in cells treated with tamoxifen alone (Figure 4A). The tamoxifen and NDGA drug combination proved to be more effective. Dose-response showed significant inhibition in proliferation compared with the control population (Figure 4B).
|
| ASSESSMENT WITHIN A RESEARCH SETTING |
|---|
|
|
|---|
The following data are summarized from an external evaluation completed for the National Institutes of Health-Science and Education Partnership Award grant that funds this unique precollege/undergraduate research internship.
Student Assessment of the Research Experience
Precollege. Over the past 5 yr, 498 of the program's 735
students have come from a traditionally defined minority population, and
female participation is consistently at 50% to 56%. These data, which mirror
regional public school demographics, would indicate that gender and
racial/ethnic inequality is minimal within the precollege program. Although
the mammalian cancer assay was originally conceived to "grab
attention" in light of the high breast cancer mortality rates within
minority communities, our experience has demonstrated that scientific
investigations consistently engage participants when targeted to any
adolescent interest.
All students are treated like laboratory investigators, in that the more-focused students move more quickly to the next experiment and less-skilled students are given every opportunity to try again. As indicated in Figure 5, doing research science, regardless of the specific discipline, has measurable effects on student attitudes. The antiproliferative cancer assay requires a student to remain involved with the experiment for a week. This commitment to a single concept, combined with daily assessments of cell viability, allows students to assume responsibility for their own learning. Tools and techniques become the framework for critical thinking and the construction of explanations. Through peer-to-peer critiques, their skills are spotlighted and applauded.
|
As one part of an extensive pre-/post-2003 attitude survey, students were given seven questions that focused on whether they liked "doing" or "listening" or "watching." "Doing an experiment" with only a protocol was the overwhelming favorite, as seen in column three of Figure 5.
Although the above data demonstrate that the students obviously enjoyed a research internship, the question of their continued interest in the sciences can only be implied. Our program has expanded from six students to 216 students over 5 yr (waiting lists excluded). Currently, 100% of our senior students continue their education (20 seniors/yr only), 100% of returning students have taken another mathematics and/or science course, approximately 40% of our high school students participated in a science fair/building competition, and approximately 25% of the high school students returned for another year or more. Because of funding limitations, we can only anecdotally report that many students not returning to our program do attend a different summer internship. Furthermore, because the facility is not an accredited educational institution, legal barriers prohibit longer term data collection on minors.
Undergraduate. The breast cancer model has become a training tool for most undergraduates throughout the facility. During the external evaluation, 26 undergraduate researchers who had also participated in the precollege internships and the breast cancer investigation were asked to complete an eight-page postexperience survey.
|
A similar undergraduate survey was administered in a pre- and postformat to all undergraduate interns (n = 82) in 2003. A preliminary analysis indicates that Figure 6 reflects the undergraduates' feelings across the facility. Given current retention and dismissal rates within the facility, we estimate that 98% of the undergraduate interns are prepared for further responsibilities within a week. A facility-wide review showed that 38% of all our undergraduate interns originate in a traditional minority population. This suggests that many of our high school students advance to undergraduate work at the facility and that minority students regard the WRAIR as a known internship opportunity. In addition, 43% of our undergraduates return for an additional year or more of internship.
Formative Evaluation. At the precollege level, an anonymous 2004 evaluation showed that high school students, age 15-18 yr, generally found the technical difficulty of the breast cancer experiments to be appropriate. Students were also asked to rate their interest in the individual protocols on a Likert-type scale from 1 (not interesting) to 5 (very interesting). Cell culture and maintenance and the introduction to breast cancer research scored 4.3 ± 0.6, cell plating and the drug assay scored 4.1 ± 0.6, and analysis of the drugs and discussion of their nature scored 4.1 ± 0.5. Students often announce that plating cells is boring and drawing plots is hard. Yet many of these same students ask to return to test herbal remedies. They had experienced the process of cell biology and had become excited about discovery.
Every student who has ever participated in the antiproliferative drug assay has obtained results that could be displayed and then analyzed. The sense of accomplishment that a student gains from conducting "my own research" solidifies their learning in advanced topics such as apoptotic pathways or the genetic basis behind deregulated protein cascades. At the same time, the students' active involvement in protocol design and data gathering shifts the stress of learning from rote memorization to memorable initiative taking.
| DISCUSSION |
|---|
|
|
|---|
The breast cancer experiment, as well as others designed by WRAIR scientists, follows a compromise approach between the "cookbook laboratory" and the "individually conceived science project." With our program, we learned early that "hands-on" is not enough to guarantee student learning. We noted that although students could be taught to manipulate equipment during an experiment, they could not necessarily apply their skills to a different project. These anecdotal observations, as reported by the scientists who helped launch the program, led to a change in the experimental emphasis from a hands-on to an inquiry method. As stated by both the American Association for the Advancement of Science (AAAS) and National Research Council (NRC) "inquiry is a set of interrelated processes by which scientists and students pose questions about the natural world and investigate phenomena; in doing so, students acquire knowledge and develop a rich understanding of concepts, principles, models and theories" (AAAS, 1993; NRC, 1995). The breast cancer experiment was one of the first investigations to diminish focus on technique to enhance the focus on concepts.
For the breast cancer cell training exercise, robust cells were selected to compensate for inexperience. Appendices became flexible so that more less-experienced students did less of the cell culture work and more-experienced students continued to maintain their own flasks. The structured daily protocols were refined, whereas the open-ended nature of the results was expanded and the initial emphasis on drug chemistry was replaced with the excitement of an unknown. These changes were quickly adopted by scientists at the WRAIR, who consistently work with students ranging from 16-yr-olds to fourth-year undergraduates. In fact, our investigators have revitalized their laboratory instruction by employing an inquiry emphasis on the breast cancer investigation and similar experiments (Shupp et al., 2005). In the breast cancer study, their generalized knowledge base is placed in context and made relevant through the experience of personally witnessing the life and death of cells. Initially students are hesitant to begin an experiment that does not include an answer key. In point of fact, the older, more academically polished student usually experiences the greatest difficulty when handed the protocol. The instructor must be patient with the pleas of "What do you want me to do?" and "What if I mess up and do it wrong?" and an investigator's personal favorite, "What is the answer?" However, by the end of the second day, most of the students are completely engaged with their project and become offended if another intern/instructor intervenes without express permission.
The WRAIR, a premier research and training facility, has developed a student internship model and experiments that can be duplicated in any private or public research laboratory. From the research scientist's viewpoint, the learning objectives are straightforward: Can the intern assume independent responsibility for an experiment that integrates basic cell biology techniques with producing reproducible laboratory notes and a standard experimental summary? Using integrated, independent projects such as the breast cancer investigation, the senior scientist can assess the student's research acumen, initiative, and ability to work with the laboratory team.
| APPENDIX A |
|---|
|
|
|---|
Preparation of Media The cells are grown in Eagle's Minimal Essential medium (EMEM) with Earle's BSS and 2 mM L-glutamine that is modified by ATCC to contain 1.0 mM sodium pyruvate, 0.1 mM nonessential amino acids, and 1.5 g/L sodium bicarbonate.
Before use, filter EMEM through a 0.2-lm filter unit and supplement with 50 mL of 10% fetal bovine serum and 5 mL of Pen-Strep (10,000 units/mL penicillin and 100 µg/mL streptomycin).
Handling Procedure for Frozen Cells All steps should be carried out in a sterile biological hood. Upon receipt of the culture, the cells should be thawed rapidly and initiated to maintain the highest level of viability. If continued storage is necessary, the frozen culture should be stored in liquid nitrogen vapor phase.
Media Renewal Media renewal should be done two to three times weekly. Media should be checked for:
Subculturing Procedure for Flask Cultures Because these cells grow rapidly, it is recommended that subculture be done two times weekly at a ratio of 1:2. All volumes used in the following protocol are for a 75-cm2 tissue culture flask and can be reduced or augmented as necessary.
10 min) or back in the
incubator (
5 min) until the trypsin begins to look cloudy. | APPENDIX B |
|---|
|
|
|---|
Cell Culture Detachment Follow steps 1-11 of "Subculturing Procedure for Flask Cultures" in Appendix A for four flasks of MMT cells grown to a confluent monolayer.
Obtain two 50-mL tubes and divide the mixture of cells and trypsin-EDTA solution from each flask into the two tubes.
Balance the 50-mL tubes in a centrifuge and set the speed at 1,200-1,500 rpm and a temperature of 4°C for a period of 5 min.
Remove the tubes and look for a small white pellet of cells in the bottom. (If a pellet has not formed, continue to centrifuge the cells for an additional 5 min at the same settings.) Very gently pour off the supernatant, making certain the pellet stays in place.
Pipette 3 mL of medium into each tube and mix by gently pipetting. Combine suspended cells from both tubes into one tube. Rinse the empty tube with 1 mL of medium; add this volume to the tube containing the suspended cells and vortex briefly.
Pipette 10 µL of suspended cells into a 1.5-mL tube. Add 90 µL of prepared trypan blue dye (0.4% trypan blue dye and sterile distilled water in 1:25 dilution). Vortex at a low speed.
The instructor calculates the cell concentration with a hemocytometer (see Appendix D, Day 3, for student review). Using the cell concentration worksheet (answer key below) ensure that there are 5 3 104 cells/mL for plating. If there are insufficient cells, the instructor should perform trypsinization on additional flasks or alter the number of cells that should be present in each well of the 96-well plate. The total amount of cell suspension required will depend upon the size of the class.
Cell Concentration Worksheet (Solution)
We want a concentration of 10,000 cells suspended in 200 µL of medium in
each well of a 96-well plate. Find the concentration of cells per milliliter
that is in each well. Show calculations below. (Hint: 1 mL = 1,000
µL)
![]() |
![]() |
From the hemocytometer, a device used to measure the concentration of cells
in a cell-medium suspension, the researcher obtains two cell counts.
![]() |
![]() |
Find the average cell count.
![]() |
The average cell count will allow us to calculate the concentration of
cells in our cell-medium suspension. Earlier, we had done a 10:1 dilution with
trypan blue dye, the dye that allows us to visualize cells on our
hemocytometer. Therefore, we must now multiply the average cell count by 10.
![]() |
Multiply this number by 104 cells/mL. This gives the
concentration of cells in medium that we currently have.
![]() |
We have 6 mL of cell-medium suspension in our container. Multiply the
concentration by 6 mL to obtain the total number of cells in the container.
![]() |
Remember from step 1 that we want to obtain a final cell concentration of 5
x 104 cells/mL from our current cell concentration of 330
x 104 cells/mL. To do so, we must add medium to our 6 mL of
cells to dilute to the desired concentration. Find the amount of medium we
must add.
![]() |
However, we might not need nearly this amount of cell suspension. Say, for example, that 120 mL of cell suspension is all that is needed.
That could be obtained by taking 2 mL of cell suspension and adding 130 mL of medium.
| APPENDIX C |
|---|
|
|
|---|
|
|
|
|
|
Other drugs, such as 5-fluorouracil, can also be used effectively. Our facility has also tested simple pharmacological agents such as aspirin, hydrogen peroxide, antibiotics, and various herbs to give the students an opportunity to design "their own" study.
| APPENDIX D Student Guide |
|---|
|
|
|---|
Two 96-well plates/student or team
1 50-mL tube containing known concentration of MMT cells
1 15-mL tube containing sterile distilled water
Several repeaters
Bicomb Eppendorf tips for the repeater (1 = 100 µL)
Personal protective equipment (PPE): lab coat, goggles, gloves
Demonstration plate
Procedure
Background information on breast cancer and any applicable
review.
Plating Cells: Students will plate their own cells. This protocol should be carried out under sterile conditions either on a clean bench or in a bio-safety hood. The students and instructor must wear gloves, lab coat, and goggles.
As an example for the class, the instructor should have a properly labeled demonstration plate on the bench.
Cell Plating
Take one 96-well plate into the sterilized hood. Open the packaging, being
careful not to take the lid off of the plate.
Cells are incubated until
70% confluence, usually 24 h
(Figure 1).
DAY 2
Introduction to Drug Dilutions and Performing a Cellular Drug Resistance Assay
Materials
Drug Assay Worksheets
2 1.5-mL tubes each containing an unknown drug or combination of drugs
1 15-mL tube containing modified EMEM cell media
1 24-well plate
2 96-well plates containing confluent MMT cells (from day 1)
1,000, 100, and 10-µL pipettes with tips
Several repeaters
Bicomb Eppendorf tips for the repeater (1 = 50 µL)
PPE: lab coat, goggles, gloves
Demonstration plate
Procedure
Cell Concentration Worksheet. Students and teacher complete the
formula sheet to calculate the final cell/medium suspension required for the
sample number provided by the instructor. This can be done in the classroom or
at the bench.
Drug Assay Worksheet. Each student will receive two drugs from the instructor for each 96-well plate. Fill out the appropriate Drug Assay Worksheet for each drug. These worksheets will be used later today.
The instructor should have a demonstration plate that illustrates how to label the additional information on the 96-well plate.
Each person has received two vials of unknown drugs. We will now prepare several different dilutions of each of the two drugs on 24-well plates. These will later be added to our plated cells.
Place the appropriate drug dilution sheets close by so they can be easily read.
This procedure can be repeated to make the second drug's dilution.
Performing the Drug Assay or Plating the Dilutions
When finished, place all plates back into the incubator. Clean up the area and wipe all surfaces down with 70% ethanol.
DAY 3
Your class will receive an aliquot of MMT cells of unknown cell
concentration. Using a hemocytometer, you will calculate the cell
concentration as well as the dilution required to achieve the required 10,000
cells suspended in 200 µL of medium. Once the cells are diluted and
concentration is confirmed, the cells can be returned to a tissue culture
flask.
Using a Hemocytometer to Estimate Cell Concentration Pipette 10 µL of suspended cells into a 1.5-mL tube. Add 90 µL of prepared trypan blue dye (0.4% trypan blue dye and sterile distilled water in a 1:25 dilution). Vortex at a low speed.
Place a coverslip over the slide with the hemocytometer grid. Pipette 10 µL of the cell/dye dilution into each side of the slide.
Focus the microscope on the hemocytometer grid and bring the upper left square of the large grid square into view.
Begin to count the cells found in this section of the hemocytometer grid. Record this number and move the slide to count the number of cells in the lower left corner, upper right corner, and lower right corner, recording the additional values as you continue.
Add the recorded values together and divide by four to get an average number of cells per square. This value will be known as cell count 1.
Move the focus of the microscope to the second grid of the hemocytometer and repeat this method of counting to find a second average number of cells per square for the upper half of the instrument. This value will be known as cell count 2.
Cell Concentration Worksheet
We want a concentration of 10,000 cells suspended in 200 µL of medium in
each well of a 96-well plate. Find the concentration of cells per milliliter
that is in each well. Show calculations below. (Hint: 1 mL =
1,000 µL)
![]() |
From the hemocytometer, a device used to measure the concentration of cells
in a cell-medium suspension, the researcher obtains two cell counts.
![]() |
![]() |
Find the average cell count.
![]() |
The average cell count will allow us to calculate the concentration of
cells in our cell-medium suspension. Earlier, we had done a 10:1 dilution with
trypan blue dye, the dye that allows us to visualize cells on our
hemocytometer. Therefore, we must now multiply the average cell count by 10.
![]() |
Multiply this number by 104 cells/mL. This gives the
concentration of cells in medium that we currently have.
![]() |
We have 6 mL of cell-medium suspension in our container. Multiply the
concentration by 6 mL to obtain the total number of cells in the container.
![]() |
Remember from step 1 that we want to obtain a final cell concentration of
from our current cell concentration of from our current cell
concentration of . To do so, we must add medium to our 6 mL of cells to
dilute to the desired concentration. Find the amount of medium we must add.
![]() |
DAY 4
Using data from the previous year or demonstration plates, you will learn
how to read fluorescent scan spreadsheets and how to do a simple analysis. The
breast cancer model has traditionally used CyQUANT because of its simplicity,
but other proliferation assay kits would be just as effective. Your instructor
will review the product literature to help you determine what is being
measured. Your instructor will demonstrate how to use the scanner or plate
reader to acquire and analyze the image. Also, the instructor will explain how
to save the data in a tab-delimited format and use spreadsheet data analysis
software (MS Excel, Sigma-Plot) to plot the data and carry out some
statistical analyses, such as averaging the data. Cell cultures may be frozen
at this point.
DAY 5
Cell Proliferation Assay, Scanning, and Analysis
Materials
CyQuant Cell Proliferation Assay Kit (consists of components A and B)
2 96-well plates incubated with drug assay
1,000-µL pipette with tips
Eppendorf repeater with 100-µL tips
1 50-mL tube wrapped in aluminum foil
Sterile distilled water
Scanner, inverted microscope
Procedure
Part 1: Preparation for Scanning. Prepare the plates for scanning
with the CyQuant Cell Proliferation Assay Kit.
Part 2: Analysis. Students learn how to export their data from the scanner and how to use a spreadsheet, analyze the data, and create plots. Each drug is added at increasing concentrations in four to eight wells for each concentration. Students calculate the average cell number for each concentration and divide it by the cell number in the control wells. This yields the percentage of viable cells for each treatment. The results are plotted and compared with standard curves that have been previously established by the instructor. Once the students have matched their plots to the standard, the names and nature of the drugs are revealed and discussed. The students then discuss effective drug or drug combination(s) on the basis of cell proliferation.
|
| ACKNOWLEDGMENTS |
|---|
We thank the students and teachers at the Thomas Jefferson High School for Science and Technology in Fairfax, VA, and the McKinley Technical High School, District of Columbia Public Schools, for their support.
This work was funded by National Institutes of Health, Science and Education Partnership Award: Broadening of a Basic Race and Gender Equity Program, Phase 1; 5R25RR15629-01, Phase II; 1R25RR018619-01.
| FOOTNOTES |
|---|
Undergraduate research interns. ![]()
Address correspondence to: Rasha Hammamieh (rasha.hammamieh{at}na.amedd.army.mil).
| REFERENCES |
|---|
|
|
|---|
American Association for the Advancement of Science (1993). Benchmarks for Science Literacy: Project 2061. New York: Oxford University Press.
Chagpar, A.B. (2004). Advances in the management of localized breast cancer: an overview. J. Ky. Med. Assoc. 102(5),202 -208.[Medline]
Evan, G.I., and Vousden, K.H. (2001). Proliferation, cell cycle and apoptosis in cancer. Nature 411(6835),342 -348.[CrossRef][Medline]
Grandishar, W.J. (2004). Tamoxifenwhat next?Oncologist
9(4),378
-384.
Imaginis: The Breast Health Resource (2005). http://imaginis.com/breasthealth/statistics.asp (accessed 27 March 2005).
Krzystyniak, K.L. (2002). Current strategies for anticancer chemo-prevention and chemoprotection. Acta Pol. Pharm. 59(6),473 -478.[Medline]
Lambert, J.D., and Zhao, D. (2002). Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse.Toxicon 40(12),1701 -1708.[Medline]
Lou, Z., and Chen, J. (2003). BRCA proteins and DNA damage checkpoints. Front. Biosci. 1(8),s718 -721.
McDonald, R.W., and Bunjobpon, W. (2001). Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.Anti-Cancer Drug Des. 16(6),261 -270.[Medline]
McGuffin, M., and Hobbs, C. (1997). American Herbal Products Association's Botanical Safety Handbook. Boca Raton, FL: CRC Press.
Mehta, K., and Pantazis, F. (1997). Antiproliferative effect of curcumin (diferuloymethane) against human breast tumor cell lines.Anticancer Drugs 8(5),470 -481.[Medline]
National Research Council (1995). National Science Education Standards. Washington, DC.: National Academy Press,214 .
Radice, P. (2002). Mutations of BRCA genes in hereditary breast and ovarian cancer. J. Exp. Clin. Cancer Res. 21(3 Suppl),9 -12.[Medline]
Sheikh, N.M., and Philen, P.M. (1997).
Chaparral-associated hepatotoxicity. Arch. Intern. Med.
157(8),913
-919.
Shupp, J., Yourick, D., Jett, M., and Anderson, M.K. (2005). Cell wars: a laboratory model for macrophage phagocytosis of gram-negative bacteria. American Society of Microbiology. http://www.microlibrary.org (posted 2 January 2005 and accessed 27 March 2005).
Strauss, E. (1999). Pretesting tumors. Sci. Am. 280(2),19 -23.[Medline]
Teh, S.H., and Hill, A.K. (2004). COX inhibitors modulate bFGF-induced cell survival in MCF-7 breast cancer cells. J Cell Biochem. 91(4),796 -807.[CrossRef][Medline]
Tong, W., and Ding, X. (2002). Lipoxygenase inhibitors
attenuate growth of human pancreatic cancer xenographs and induce apoptosis
through the mitochondrial pathway. Mol. Cancer Ther.
1(11),929
-935.
Wallace, J.M. (2002). Nutritional and botanical
modulation of the inflammatory cascadeeicosanoids, cyclooxygenases, and
lipoxygenasesas an adjunct in cancer therapy. Integr. Cancer
Ther. 1(1),7
-37.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | ARCHIVE | SEARCH | TABLE OF CONTENTS |